Patents by Inventor Stephen Thomson

Stephen Thomson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12331057
    Abstract: The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I): tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds.
    Type: Grant
    Filed: October 16, 2023
    Date of Patent: June 17, 2025
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Upul Keerthi Bandarage, Cavan McKeon Bligh, Diane Boucher, Michael John Boyd, Michael Aaron Brodney, Michael Philip Clark, Veronique Damagnez, Lev Tyler Dewey Fanning, Robert Francis Fimognari, Gabrielle Simone Fleming, Kevin James Gagnon, Pedro Manuel Garcia Barrantes, Robert Daniel Giacometti, Simon Giroux, Ronald Lee Grey, Jr., Samantha Guido, Amy Beth Hall, Sarah Carol Hood, Dennis James Hurley, Mac Arthur Johnson, Jr., Peter Jones, Sarathy Kesavan, Mei-Hsiu Lai, Siying Liu, Adam Looker, Brad Maxwell, John Patrick Maxwell, Ales Medek, Philippe Marcel Nuhant, Kirk Alan Overhoff, Setu Roday, Stefanie Roeper, Steven M. Ronkin, Rupa Sawant, Yi Shi, Muna Shrestha, Marisa Sposato, Kathy Stavropoulos, Rebecca Jane Swett, Timothy Lewis Tapley, Qing Tang, Stephen Thomson, Jinwang Xu, Mariam Zaky, Kevin Michael Cottrell
  • Publication number: 20240336614
    Abstract: The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I): tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds.
    Type: Application
    Filed: October 16, 2023
    Publication date: October 10, 2024
    Inventors: Upul Keerthi BANDARAGE, Cavan McKeon BLIGH, Diane BOUCHER, Michael John BOYD, Michael Aaron BRODNEY, Michael Philip CLARK, Veronique DAMAGNEZ, Lev Tyler Dewey FANNING, Robert Francis FIMOGNARI, Gabrielle Simone FLEMING, Kevin James GAGNON, Pedro Manuel GARCIA BARRANTES, Robert Daniel GIACOMETTI, Simon GIROUX, Ronald Lee GREY, JR., Samantha GUIDO, Amy Beth HALL, Sarah Carol HOOD, Dennis James HURLEY, Mac Arthur JOHNSON, JR., Peter Jones, Sarathy KESAVAN, Mei-Hsiu LAI, Siying LIU, Adam LOOKER, Brad MAXWELL, John Patrick MAXWELL, Ales MEDEK, Philippe Marcel NUHANT, Kirk Alan OVERHOFF, Setu RODAY, Stefanie ROEPER, Steven M. RONKIN, Rupa SAWANT, Yi SHI, Muna SHRESTHA, Marisa SPOSATO, Kathy STAVROPOULOS, Rebecca Jane SWETT, Timothy Lewis TAPLEY, Qing TANG, Stephen THOMSON, Jinwang XU, Mariam ZAKY, Kevin Michael COTTRELL
  • Publication number: 20240246918
    Abstract: Described herein are compounds of Formula I, and their pharmaceutically acceptable salts, solvates, stereoisomers, or prodrugs, as well as their uses (e.g., as eIF4E inhibitors).
    Type: Application
    Filed: November 13, 2023
    Publication date: July 25, 2024
    Inventors: Rajeev BHIDE, Roheeth Kumar PAVANA, Stephen THOMSON, Ashis Kumar SAHA, Ramamurty V S CHANGALVALA, Stevan DJURIC, Ramesh Kumar SISTLA, Sundara Raghuram TANGIRALA, Laxmikant Shamlal DATRANGE, Samir Satish KHER, Saumya ROY, Suparna GUPTA, Michael PATANE, Ratnakumar SREEKANTHA, Simon HAYDER
  • Patent number: 11884672
    Abstract: The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I): tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds.
    Type: Grant
    Filed: May 13, 2020
    Date of Patent: January 30, 2024
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Upul Keerthi Bandarage, Cavan McKeon Bligh, Diane Boucher, Michael John Boyd, Michael Aaron Brodney, Michael Philip Clark, Veronique Damagnez, Lev Tyler Dewey Fanning, Robert Francis Fimognari, Gabrielle Simone Fleming, Kevin James Gagnon, Pedro Manuel Garcia Barrantes, Robert Daniel Giacometti, Simon Giroux, Ronald Lee Grey, Jr., Samantha Guido, Amy Beth Hall, Sarah Carol Hood, Dennis James Hurley, Mac Arthur Johnson, Jr., Peter Jones, Sarathy Kesavan, Mei-Hsiu Lai, Siying Liu, Adam Looker, Brad Maxwell, John Patrick Maxwell, Ales Medek, Philippe Marcel Nuhant, Kirk Alan Overhoff, Setu Roday, Stefanie Roeper, Steven M. Ronkin, Rupa Sawant, Yi Shi, Muna Shrestha, Marisa Sposato, Kathy Stavropoulos, Rebecca Jane Swett, Timothy Lewis Tapley, Qing Tang, Stephen Thomson, Jinwang Xu, Mariam Zaky, Kevin Michael Cottrell
  • Publication number: 20200361939
    Abstract: The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I): tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds.
    Type: Application
    Filed: May 13, 2020
    Publication date: November 19, 2020
    Inventors: Upul Keerthi BANDARAGE, Cavan McKeon BLIGH, Diane BOUCHER, Michael John BOYD, Michael Aaron BRODNEY, Michael Philip CLARK, Veronique DAMAGNEZ, Lev Tyler Dewey FANNING, Robert Francis FIMOGNARI, Gabrielle Simone FLEMING, Kevin James GAGNON, Pedro Manuel GARCIA BARRANTES, Robert Daniel GIACOMETTI, Simon GIROUX, Ronald Lee GREY, Jr., Samantha GUIDO, Amy Beth HALL, Sarah Carol HOOD, Dennis James HURLEY, Mac Arthur JOHNSON, Jr., Peter Jones, Sarathy KESAVAN, Mei-Hsiu LAI, Siying LIU, Adam LOOKER, Brad MAXWELL, John Patrick MAXWELL, Ales MEDEK, Philippe Marcel NUHANT, Kirk Alan OVERHOFF, Setu RODAY, Stefanie ROEPER, Steven M. RONKIN, Rupa SAWANT, Yi SHI, Muna SHRESTHA, Marisa SPOSATO, Kathy STAVROPOULOS, Rebecca Jane SWETT, Timothy Lewis TAPLEY, Qing TANG, Stephen THOMSON, Jinwang XU, Mariam ZAKY
  • Patent number: 9650264
    Abstract: A fluid conditioning control system for driving one or more coils in a fluid conditioning system with a target load current to generate an alternating magnetic field directed at a fluid, the control system comprising a controller, a switch mode power supply circuit and a push pull AC drive circuit, wherein the controller is arranged to develop a first variable output having a frequency range that sweeps between a minimum frequency and a maximum frequency, and further arranged to develop a second variable output in the form of a duty cycle controlled signal, wherein the switch mode power supply circuit is arranged to develop a variable supply voltage to the AC drive circuit in response to the second variable output and a current sense circuit, and the AC drive circuit is arranged to develop a drive signal for developing a target load current in response to the first variable output and the variable supply voltage, thereby forming a current feedback loop.
    Type: Grant
    Filed: March 26, 2013
    Date of Patent: May 16, 2017
    Assignee: Calclear Investments Pty Limited
    Inventors: Robyn Anne Fayle, Stephen Thomson
  • Publication number: 20150090593
    Abstract: A fluid conditioning control system for driving one or more coils in a fluid conditioning system with a target load current to generate an alternating magnetic field directed at a fluid, the control system comprising a controller, a switch mode power supply circuit and a push pull AC drive circuit, wherein the controller is arranged to develop a first variable output having a frequency range that sweeps between a minimum frequency and a maximum frequency, and further arranged to develop a second variable output in the form of a duty cycle controlled signal, wherein the switch mode power supply circuit is arranged to develop a variable supply voltage to the AC drive circuit in response to the second variable output and a current sense circuit, and the AC drive circuit is arranged to develop a drive signal for developing a target load current in response to the first variable output and the variable supply voltage, thereby forming a current feedback loop.
    Type: Application
    Filed: March 26, 2013
    Publication date: April 2, 2015
    Inventors: Robyn Anne Fayle, Stephen Thomson
  • Patent number: 7763133
    Abstract: A method of transporting a liquid product down a vertical conduit having an inlet provided at the top of the conduit and an outlet provided at the bottom of the conduit, which method comprises feeding the liquid product into the inlet of the conduit and contacting the liquid product with means for dissipating potential energy released by the liquid product as it is transported down the conduit so that turbulence in the liquid product at the outlet of the conduit is reduced.
    Type: Grant
    Filed: March 26, 2004
    Date of Patent: July 27, 2010
    Assignee: Orica Explosives Technology Pty Ltd.
    Inventor: Stephen Thomson
  • Publication number: 20070249670
    Abstract: The invention relates to glycogen phosphorylase inhibitor compounds, pharmaceutical compositions of these compounds, methods of treatment using the pharmaceutical compositions to treat diabetes, conditions associated with diabetes, and/or tissue ischemia, including myocardial ischemia, and processes for making the compounds.
    Type: Application
    Filed: November 4, 2005
    Publication date: October 25, 2007
    Applicant: SMITHKLINE BEECHAM CORPORATION
    Inventors: Karen Evans, Maria Cichy-Knight, Frank Coppo, Kate Dwornik, Jennifer Gale, Dulce Garrido, Yue Li, Mehul Patel, Francis Tavares, Stephen Thomson, Scott Dickerson, Andrew Peat, Steven Sparks, Pierette Banker, Joel Cooper
  • Publication number: 20060237492
    Abstract: A method of transporting a liquid product down a vertical conduit having an inlet provided at the top of the conduit and an outlet provided at the bottom of the conduit, which method comprises feeding the liquid product into the inlet of the conduit and contacting the liquid product with means for dissipating potential energy released by the liquid product as it is transported down the conduit so that turbulence in the liquid product at the outlet of the conduit is reduced.
    Type: Application
    Filed: March 26, 2004
    Publication date: October 26, 2006
    Applicant: Orica Explosives Technology Pty Ltd.
    Inventor: Stephen Thomson
  • Publication number: 20060167020
    Abstract: The present invention relates generally to inhibitors of the kinases and more particularly to novel pyrazolopyrimidine compounds.
    Type: Application
    Filed: July 21, 2003
    Publication date: July 27, 2006
    Inventors: Scott Dickerson, Dulce Garrido, Wendy Mills, Kazuya Kano, Andrew Peat, Stephen Thomson, Jayme Wilson, Hui-Quiang Zhou
  • Publication number: 20050267133
    Abstract: The present invention relates generally to inhibitors of the kinases and more particularly to novel pyrazolopyrimidine compounds
    Type: Application
    Filed: July 21, 2003
    Publication date: December 1, 2005
    Inventors: Matthew Brown, Mui Cheung, Scott Dickerson, David Drewry, Karen Lackey, Andrew Peat, Stephen Thomson, James Veal, Jayme Wilson
  • Patent number: 6877432
    Abstract: Apparatus for delivering an emulsion explosives composition comprising unpressurized vessel (10) for storing or supplying the explosives composition to pressure chamber (1); sealable chamber inlet (2) for charging chamber (1) with emulsion explosives composition from vessel (10); and chamber outlet (4). Fluid pressure opening (6) applies a discharge pressure to chamber (1) for delivering emulsion explosives composition through outlet (4) to delivery hose (11) for charging blast holes. The apparatus is characterized by pressure chamber (1) having a maximum operating pressure and a volume such that the pressure volume (pV) value of chamber (1) is less than 10 MPaL.
    Type: Grant
    Filed: October 4, 2001
    Date of Patent: April 12, 2005
    Assignee: Orica Explosives Technology PTY LTD
    Inventors: Stephen Thomson, David Brian Kay
  • Publication number: 20050059662
    Abstract: A variety of small molecule, guanidine-containing molecules capable of acting as MC4-R agonists are provided. The compounds are useful in treating MC4-R mediated diseases when administered to subjects. The compounds have the structure IA, IB, and IC where the values of the variables are defined herein.
    Type: Application
    Filed: May 21, 2004
    Publication date: March 17, 2005
    Inventors: Rustum Boyce, Natalia Aurrecoechea, Daniel Chu, Aaron Smith, Christopher Conlee, Brian Thompson, Judith Kuntz, David Musso, Kevin Barvian, Stephen Thomson, William Swain, Kien Du, Brian Chauder, Jason Speake, Michael Bishop
  • Publication number: 20030159610
    Abstract: Apparatus for delivering an emulsion explosives composition comprising unpressurised vessel (10) for storing or supplying the explosives composition to pressure chamber (1); sealable chamber inlet (2) for charging chamber (1) with emulsion explosives composition from vessel (10); and chamber outlet (4). Fluid pressure opening (6) applies a discharge pressure to chamber (1) for delivering emulsion explosives composition through outlet (4) to delivery hose (11) for charging blast holes. The apparatus is characterisedby pressure chamber (1) having a maximum operating pressure and a volume such that the pressure volume (pV) value of chamber (1) is less than 10 MPaL.
    Type: Application
    Filed: March 21, 2003
    Publication date: August 28, 2003
    Inventors: Stephen Thomson, David Brian Kay
  • Patent number: 6209458
    Abstract: A device for locating and inflating a blasthole plug comprising; (i) a shroud adapted to enclose at least part of a deflated plug as the deflated plug is passed along a blasthole, (ii) an ejection means for removing the deflated plug from the shroud into a desired location in a blasthole, and (iii) an inflation means adapted to be removably connected to the plug, such that when the deflated plug is removed from the shroud, fluid material may be passed through the inflation means to inflate the plug.
    Type: Grant
    Filed: July 6, 1999
    Date of Patent: April 3, 2001
    Assignee: Orica Australia Pty Ltd.
    Inventors: Stephen Thomson, Andrew M Gresham
  • Patent number: 6070511
    Abstract: An apparatus and process for the production of any emulsion explosives composition and loading it into a blast hole (7) which utilize a loading conduit (4) having a shear inducing means (5) and a liquid lubrication source (b) adapted to provide a layer of liquid lubricant between the conduit (4) and emulsion explosives composition being pumped through the loading conduit (4). The conduit also comprises a mixing means (8) located at or near the outlet of the conduit (4), the mixing means (8) incorporates at least some of the liquid layer into the emulsion explosives composition.
    Type: Grant
    Filed: August 26, 1997
    Date of Patent: June 6, 2000
    Assignee: Orica Explosives Technology Pty Ltd
    Inventors: Anthony Martin Palmer, Stephen Thomson
  • Patent number: 5979327
    Abstract: A device and process for plugging an explosives blasthole, the device having an inner member (7a, 7b) in the form of a conduit having a valve (9) and being adapted for the passage of fluid bulk explosives and an outer member (1) adapted to engage the walls of the blasthole. The outer member may be made of deformable material or be inflatable. The inner and outer members may be detachable.
    Type: Grant
    Filed: June 26, 1998
    Date of Patent: November 9, 1999
    Assignee: Orica Australia Pty Ltd
    Inventor: Stephen Thomson